Form 8-K - Current report:
SEC Accession No. 0001193125-25-005319
Filing Date
2025-01-13
Accepted
2025-01-13 16:17:17
Documents
15
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d890861d8k.htm   iXBRL 8-K 25948
2 EX-99.1 d890861dex991.htm EX-99.1 21743
6 GRAPHIC g890861g90r43.jpg GRAPHIC 5978
  Complete submission text file 0001193125-25-005319.txt   179957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20250113.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20250113_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20250113_pre.xml EX-101.PRE 10816
17 EXTRACTED XBRL INSTANCE DOCUMENT d890861d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 25526561
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)